Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2025-12-25 @ 4:06 AM
NCT ID:
NCT02153320
Eligibility Criteria:
Inclusion Criteria:
* Subjects who the investigator believes can and will comply with the requirements of the protocol.
* Subjects who took part in and completed study 287615 (NCT00508833).
* Written informed consent obtained from the subject.
* Healthy subjects as established by medical history before entering into the study.
Exclusion Criteria:
* Use of any investigational or non-registered product other than the study vaccine(s) within 30 days preceding the blood sampling, or planned use during the study period.
* Chronic administration of immunosuppressants or other immune-modifying drugs within three months prior to the blood sampling.
* Administration of immunoglobulins within the three months preceding the blood sampling or planned administration during the study period.
* Pregnant or lactating female.
* Documented HIV-positive subject.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
22 Years
Maximum Age:
45 Years
Study:
NCT02153320
Study Brief:
Protocol Section:
NCT02153320